KalVista Stock Soars Pre-Market On FDA Approval For Drug In Treating Swelling Disorder: Retail’s Elated Ekterly is the first and only oral on-demand treatment for hereditary angioedema, KalVista said, setting it apart from other on-demand treatment options approved in the U.S., which require intravenous or subcutaneous administration.
KalVista Ends Its Unexpectedly Messy Path To Approval In HAE Treatment The FDA signed off on KalVista Pharmaceuticals' emergency treatment for swelling attacks associated with a rare disease.
Insiders Buying Dorian LPG And 2 Other Stocks Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
FDA Approves KalVista's Ekterly As First Oral On-Demand Treatment For Rare Swelling Disease KalVista's Ekterly, backed by strong trial data, receives FDA approval as the first oral therapy for acute hereditary angioedema attacks in the US.
How KalVista Pharma Is Taking On A Rare But Deadly Disease The company is working on the first new on-demand treatment for hereditary angioedema in 11 years.
KALV Stock Earnings: KalVista Pharma Misses EPS for Q4 2024 KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the fourth quarter of 2024.
Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
What's Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday? Results from KalVista Pharmaceuticals' Phase 3 KONFIDENT trial. Sebetralstat, an oral on-demand therapy, shows efficacy for hereditary angioedema.
Insiders Buying Monro And 3 Other Stocks Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
$230M Bet On Talos Energy? Check Out These 4 Stocks Insiders Are Buying Although U.S. stocks closed higher on Friday, there were a few notable insider trades.
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.
